← back to search

Allard C. van der Wal

Maastricht University Medical Centre · NL
🔎 Find collaborators in Surgery · Immunology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Surgery · Immunology
Research interest
Research interests include Atherosclerosis and Cardiovascular Diseases, Coronary Interventions and Diagnostics, Colorectal and Anal Carcinomas, and Cervical Cancer and HPV Research.
h-index
68
citations
20,787
works
386
NIH funding
primary concept
Medicine
email

Recent publications

Ischemic and non-ischemic myocardial injuries at autopsy- an overview for forensic pathologists.
2025cited by 2position: contributordoi
Supplementary Data TS3 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of High-Grade Anal Intraepithelial Neoplasia in HIV<sup>+</sup> Men
2025cited by 0position: contributordoi
Supplementary Data FS2 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of High-Grade Anal Intraepithelial Neoplasia in HIV<sup>+</sup> Men
2025cited by 0position: contributordoi
Data from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of High-Grade Anal Intraepithelial Neoplasia in HIV<sup>+</sup> Men
2025cited by 0position: contributordoi
Supplementary Data FS1 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of High-Grade Anal Intraepithelial Neoplasia in HIV<sup>+</sup> Men
2025cited by 0position: contributordoi
Supplementary Data MS2 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of High-Grade Anal Intraepithelial Neoplasia in HIV<sup>+</sup> Men
2025cited by 0position: contributordoi
Supplementary Data MS1 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of High-Grade Anal Intraepithelial Neoplasia in HIV<sup>+</sup> Men
2025cited by 0position: contributordoi
Supplementary Data FS3 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of High-Grade Anal Intraepithelial Neoplasia in HIV<sup>+</sup> Men
2025cited by 0position: contributordoi
Supplementary Data TS2 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of High-Grade Anal Intraepithelial Neoplasia in HIV<sup>+</sup> Men
2025cited by 0position: contributordoi
Supplementary Data TS1 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of High-Grade Anal Intraepithelial Neoplasia in HIV<sup>+</sup> Men
2025cited by 0position: contributordoi
Coronary CT angiography for the assessment of atherosclerotic plaque inflammation: postmortem proof of concept with histological validation.
2024cited by 5position: contributordoi
Enrichment of type 1 innate lymphoid cells in the course of human atherosclerotic plaque development suggests contribution to atherogenesis.
2024cited by 3position: contributordoi
Cardiovascular pathology in vasculitis.
2024cited by 2position: contributordoi
High-risk coronary plaque of sudden cardiac death victims: postmortem CT angiographic features and histopathologic findings.
2024cited by 1position: contributordoi
Age and sex disparities in myocardial ischemia-related deaths at autopsy.
2024cited by 0position: contributordoi
Supplementary Data MS1 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of Anal Intraepithelial Neoplasia in HIV+ Men
2024cited by 0position: contributordoi
Supplementary Data FS3 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of Anal Intraepithelial Neoplasia in HIV+ Men
2024cited by 0position: contributordoi
Supplementary Data FS2 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of Anal Intraepithelial Neoplasia in HIV+ Men
2024cited by 0position: contributordoi
Supplementary Data MS2 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of Anal Intraepithelial Neoplasia in HIV+ Men
2024cited by 0position: contributordoi
Supplementary Data FS2 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of Anal Intraepithelial Neoplasia in HIV+ Men
2024cited by 0position: contributordoi
Supplementary Data MS1 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of Anal Intraepithelial Neoplasia in HIV+ Men
2024cited by 0position: contributordoi
Supplementary Data TS3 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of Anal Intraepithelial Neoplasia in HIV+ Men
2024cited by 0position: contributordoi
Supplementary Data TS2 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of Anal Intraepithelial Neoplasia in HIV+ Men
2024cited by 0position: contributordoi
Supplementary Data TS1 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of Anal Intraepithelial Neoplasia in HIV+ Men
2024cited by 0position: contributordoi
Supplementary Data TS1 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of Anal Intraepithelial Neoplasia in HIV+ Men
2024cited by 0position: contributordoi
Supplementary Data TS2 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of Anal Intraepithelial Neoplasia in HIV+ Men
2024cited by 0position: contributordoi
Supplementary Data FS1 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of Anal Intraepithelial Neoplasia in HIV+ Men
2024cited by 0position: contributordoi
Supplementary Data TS3 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of Anal Intraepithelial Neoplasia in HIV+ Men
2024cited by 0position: contributordoi
Supplementary Data FS1 from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of Anal Intraepithelial Neoplasia in HIV+ Men
2024cited by 0position: contributordoi
Data from Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of Anal Intraepithelial Neoplasia in HIV+ Men
2024cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 49 papers (2020–2025)Cornelis J. M. Melief · Leiden University Medical Center44 papers (2023–2025) · 44 papers (2023–2025) · 44 papers (2023–2025)Henry JC de Vries · Netherlands Center for Occupational Diseases44 papers (2023–2025) · 44 papers (2023–2025) · 44 papers (2023–2025)Marij J. P. Welters · German BioImaging – Gesellschaft für Mikroskopie und Bildanalyse44 papers (2023–2025)Sanne Boekestijn · 44 papers (2023–2025)Wilhelmus J.T.A. Krebber · 44 papers (2023–2025)Karien C.M. Gosens · 44 papers (2023–2025)Olivier Richel · Radboud University Nijmegen44 papers (2023–2025)Nikki M. Loof · Leiden University Medical Center44 papers (2023–2025)Wim Quint · European Patent Organisation44 papers (2023–2025)Sjoerd H. van der Burg · Oncode Institute44 papers (2023–2025)Jan M. Prins · Public Health Service of Amsterdam44 papers (2023–2025)Carel J.M. van Noesel · Amsterdam University Medical Centers44 papers (2023–2025)Cristina Basso · University of Padua16 papers (2014–2025)Mary N. Sheppard · Genomics (United Kingdom)12 papers (2017–2025) · 5 papers (2021–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Surgery · Immunology →